Mingjiang Xu

2.7k total citations
33 papers, 1.9k citations indexed

About

Mingjiang Xu is a scholar working on Epidemiology, Pathology and Forensic Medicine and Immunology. According to data from OpenAlex, Mingjiang Xu has authored 33 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Epidemiology, 13 papers in Pathology and Forensic Medicine and 8 papers in Immunology. Recurrent topics in Mingjiang Xu's work include Liver Disease Diagnosis and Treatment (14 papers), Alcohol Consumption and Health Effects (12 papers) and Eicosanoids and Hypertension Pharmacology (5 papers). Mingjiang Xu is often cited by papers focused on Liver Disease Diagnosis and Treatment (14 papers), Alcohol Consumption and Health Effects (12 papers) and Eicosanoids and Hypertension Pharmacology (5 papers). Mingjiang Xu collaborates with scholars based in United States, China and Spain. Mingjiang Xu's co-authors include Bin Gao, Zhou Zhou, Yan Cai, Dechun Feng, Hua Wang, Adeline Bertola, Yong He, Zhou Zhou, Suthat Liangpunsakul and Haixia Cao and has published in prestigious journals such as Hepatology, Gut and Scientific Reports.

In The Last Decade

Mingjiang Xu

33 papers receiving 1.9k citations

Peers

Mingjiang Xu
Aditya Ambade United States
Arvin Iracheta‐Vellve United States
Patrick Lowe United States
Lihua Zhu China
Chantal A. Rivera United States
Fengyun Xu United States
Shunhei Yamashina Japan
Yulia A. Nevzorova Germany
Tim Hendrikx Netherlands
Aditya Ambade United States
Mingjiang Xu
Citations per year, relative to Mingjiang Xu Mingjiang Xu (= 1×) peers Aditya Ambade

Countries citing papers authored by Mingjiang Xu

Since Specialization
Citations

This map shows the geographic impact of Mingjiang Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mingjiang Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mingjiang Xu more than expected).

Fields of papers citing papers by Mingjiang Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mingjiang Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mingjiang Xu. The network helps show where Mingjiang Xu may publish in the future.

Co-authorship network of co-authors of Mingjiang Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Mingjiang Xu. A scholar is included among the top collaborators of Mingjiang Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mingjiang Xu. Mingjiang Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
4.
Han, Xue, Weixin Li, Wu Luo, et al.. (2023). Macrophage DCLK1 promotes atherosclerosis via binding to IKKβ and inducing inflammatory responses. EMBO Molecular Medicine. 15(5). e17198–e17198. 31 indexed citations
5.
Park, Seol Hee, Wonhyo Seo, Mingjiang Xu, et al.. (2022). Ethanol and its Nonoxidative Metabolites Promote Acute Liver Injury by Inducing ER Stress, Adipocyte Death, and Lipolysis. Cellular and Molecular Gastroenterology and Hepatology. 15(2). 281–306. 48 indexed citations
6.
He, Yong, Dechun Feng, Seonghwan Hwang, et al.. (2021). Interleukin-20 exacerbates acute hepatitis and bacterial infection by downregulating IκBζ target genes in hepatocytes. Journal of Hepatology. 75(1). 163–176. 28 indexed citations
7.
Zhao, Weixin, Zhongxiang Xiao, Meihong Wang, et al.. (2021). Bicyclol ameliorates nonalcoholic fatty liver disease in mice via inhibiting MAPKs and NF-κB signaling pathways. Biomedicine & Pharmacotherapy. 141. 111874–111874. 20 indexed citations
8.
9.
Zhou, Zhou, Mingjiang Xu, Yan Cai, et al.. (2018). Neutrophil–Hepatic Stellate Cell Interactions Promote Fibrosis in Experimental Steatohepatitis. Cellular and Molecular Gastroenterology and Hepatology. 5(3). 399–413. 131 indexed citations
10.
Li, Man, Yong He, Zhou Zhou, et al.. (2017). MicroRNA-223 ameliorates alcoholic liver injury by inhibiting the IL-6–p47phox–oxidative stress pathway in neutrophils. Publisher. 19 indexed citations
11.
Xu, Mingjiang, et al.. (2017). Immediate Early Response Gene X‐1 (IEX‐1) Mediates Ischemic Preconditioning‐Induced Cardioprotection in Rats. Oxidative Medicine and Cellular Longevity. 2017(1). 6109061–6109061. 6 indexed citations
12.
Xu, Mingjiang, Zhou Zhou, Richard Parker, & Bin Gao. (2017). Targeting inflammation for the treatment of alcoholic liver disease. Pharmacology & Therapeutics. 180. 77–89. 62 indexed citations
13.
Lohoff, Falk W., Allison D. Rosen, Raffaele Fanelli, et al.. (2017). Methylomic profiling and replication implicates deregulation of PCSK9 in alcohol use disorder. Molecular Psychiatry. 23(9). 1900–1910. 64 indexed citations
14.
Cai, Yan, Mingjiang Xu, Erik H. Koritzinsky, et al.. (2017). Mitochondrial DNA–enriched microparticles promote acute-on-chronic alcoholic neutrophilia and hepatotoxicity. JCI Insight. 2(14). 89 indexed citations
15.
Wang, Wei, Mingjiang Xu, Yan Cai, et al.. (2017). Inflammation is independent of steatosis in a murine model of steatohepatitis. Hepatology. 66(1). 108–123. 59 indexed citations
16.
Li, Man, Yong He, Zhou Zhou, et al.. (2016). MicroRNA-223 ameliorates alcoholic liver injury by inhibiting the IL-6–p47 phox –oxidative stress pathway in neutrophils. Gut. 66(4). 705–715. 184 indexed citations
17.
Cai, Yan, Alvin Jogasuria, Huquan Yin, et al.. (2016). The Detrimental Role Played by Lipocalin-2 in Alcoholic Fatty Liver in Mice. American Journal Of Pathology. 186(9). 2417–2428. 48 indexed citations
18.
Gao, Bin & Mingjiang Xu. (2014). Chemokines and alcoholic hepatitis: are chemokines good therapeutic targets?. Gut. 63(11). 1683–1684. 22 indexed citations
19.
Xu, Mingjiang, Binxia Chang, Stephanie Mathews, & Bin Gao. (2014). New drug targets for alcoholic liver disease. Hepatology International. 8(S2). 475–480. 11 indexed citations
20.
Yin, Shi, Hua Wang, Adeline Bertola, et al.. (2014). Activation of invariant natural killer T cells impedes liver regeneration by way of both IFN-γ- and IL-4-dependent mechanisms. Hepatology. 60(4). 1356–1366. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Aditya Ambade Breakdown of academic impact, for papers by Arvin Iracheta‐Vellve Breakdown of academic impact, for papers by Patrick Lowe Breakdown of academic impact, for papers by Lihua Zhu Breakdown of academic impact, for papers by Chantal A. Rivera Breakdown of academic impact, for papers by Fengyun Xu Breakdown of academic impact, for papers by Shunhei Yamashina Breakdown of academic impact, for papers by Yulia A. Nevzorova Breakdown of academic impact, for papers by Tim Hendrikx
Rankless by CCL
2026